Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.
about
Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stressMedical management of ischemic stuttering priapism: a contemporary review of the literatureMolecular pathophysiology of priapism: emerging targetsExcess adenosine A2B receptor signaling contributes to priapism through HIF-1α mediated reduction of PDE5 gene expressionIncreased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signalingSustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse penisAdenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapismRole of adenosine signaling in penile erection and erectile disorders.Management of priapism: an update for clinicians.A2B adenosine receptor contributes to penile erection via PI3K/AKT signaling cascade-mediated eNOS activation.Priapism in sickle-cell disease: a hematologist's perspective.Impaired erectile function in CD73-deficient mice with reduced endogenous penile adenosine productionSickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 DysregulationTargeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penisAttenuated RhoA/Rho-kinase signaling in penis of transgenic sickle cell miceStuttering priapism: insights into pathogenesis and management.Nitrergic Mechanisms for Management of Recurrent PriapismHow I treat priapism.Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.Ischemic priapism: Can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis.Contemporary best practice in the evaluation and management of stuttering priapism.Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis.The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathwayExperimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.Effect of lysyl oxidase (LOX) on corpus cavernous fibrosis caused by ischaemic priapism.Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.Daily tadalafil for the chronic phase of stuttering priapism: a case report.
P2860
Q21559608-FA5CD8E5-E8DA-4190-AFB0-117A08E1C42FQ26851728-47C6BE7D-E2BF-4960-873F-F2FFC93C75AFQ27010069-16379C4E-AA87-45CA-93FF-C2A4086C2141Q33613207-E6F0E43F-B0AF-49B3-B432-4B583CB33EC1Q33694628-3FFEC2C9-A9C0-487D-9193-8788FD1CC401Q33713601-5B632284-051A-4013-99B2-617ECC2020BDQ33873920-47F5C193-FF27-4364-A80D-C4B5CF68C1A3Q34005421-6D636904-ED3B-49A0-B350-7A9057D6DE30Q34020025-89242B11-2D3C-484F-8A88-A11C190F9C86Q34536704-293FE45C-1C1C-4641-9F95-B7DBE7B7D60AQ35105343-97B5182F-9EE1-4A70-AE02-604F67DB09C9Q35658625-5D8CAE51-36EB-43D1-A0D5-3CFDD3EE1E76Q36050766-C383D40C-C502-497E-9E08-49D3E51BF27BQ36056143-812730D2-FED2-4844-AB70-8CA3CFA0D924Q36144285-85C00FD7-70DE-40D0-A7BE-26A94B8F0D3BQ36213625-5D26FBEF-A1E5-496D-B984-6DF7A08114EFQ37146167-4365CC10-8FCD-4BE3-815B-20AF7944E58AQ38014717-D24D7061-D995-45A1-A0A2-7EA353A49062Q38610620-A5EFBCB8-5533-4A4D-8BDC-A05687EED202Q39025090-C94AB0D2-97C3-495E-8900-8BAFDF451EFAQ39290264-629E7D37-79BA-4EE0-A7F6-37B79F4AD81CQ41073466-A8E318A2-AF11-4868-A689-BCBE93E7A07AQ41078738-2441BD31-28D6-4B88-BE41-28CEC19E81C3Q41826806-1173C2CE-E989-4B34-9357-9BFB4332AF71Q42603490-B531B4FE-B181-4EC1-88CB-7A6B0AD9C1C1Q42696988-82B40DBB-2E00-4BD7-8C2D-E648BB975915Q47248657-E8840252-4956-4459-9956-4EC12A045EA7Q47395261-054CA280-BE24-4790-B400-F0221A50579AQ55154654-A6FB1FFD-892C-4BF5-9FF2-6235B5809F23
P2860
Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Establishment of a transgenic ...... e pathophysiology of priapism.
@ast
Establishment of a transgenic ...... e pathophysiology of priapism.
@en
Establishment of a transgenic ...... e pathophysiology of priapism.
@nl
type
label
Establishment of a transgenic ...... e pathophysiology of priapism.
@ast
Establishment of a transgenic ...... e pathophysiology of priapism.
@en
Establishment of a transgenic ...... e pathophysiology of priapism.
@nl
prefLabel
Establishment of a transgenic ...... e pathophysiology of priapism.
@ast
Establishment of a transgenic ...... e pathophysiology of priapism.
@en
Establishment of a transgenic ...... e pathophysiology of priapism.
@nl
P2093
P2860
P1476
Establishment of a transgenic ...... e pathophysiology of priapism.
@en
P2093
Arthur L Burnett
Biljana Musicki
Hunter C Champion
Trinity J Bivalacqua
P2860
P304
P356
10.1111/J.1743-6109.2009.01359.X
P577
2009-06-11T00:00:00Z